Skip to main content
Home
  • Solutions
    Clinical solutions
    Blended Solutions Cardiac Safety Solutions Clinical & Scientific Operations Decentralised Clinical Trials Early Clinical Laboratories Medical Imaging Site & Patient Solutions Strategic Solutions
    Consulting & Commercial
    Asset Development Consulting Commercial Positioning Language Services Outcome Measures Real World Intelligence Regulatory Affairs Symphony Health data
    meeting
    Case studies

    Reducing time to market, delivering on quality, providing deep therapeutic expertise and enhancing R&D ROI.

    Innovative research tools showcase
    Technologies

    Technology solutions from early phase through to post-marketing.

  • Sectors
    Sectors

    ICON provides its full range of clinical, consulting and commercial services across several industry sectors.

    Read more
    Biotech Government and Public Health Medical Device Pharmaceuticals
    Biotechnology services navigation panel
    Biotech

    Developing transformative therapies requires a flexible approach.

    Employee engagement program overview
    ICON and You

    Partners making a difference.

  • Therapeutics
    Therapeutics
    Cardiovascular Central Nervous System Endocrine & Metabolic Disorders Hepatology Infectious Diseases Internal Medicine & Immunology Oncology
    Cross-therapeutics
    Biosimilars Cell and Gene Therapies Medical Device Pediatrics Rare & Orphan Diseases Vaccines Women's Health
    Obesity 2025 insights image
    Obesity

    A focus on combination therapies requires appropriate obesity-specific trial designs, long-term follow-up studies and diverse patient recruitment.

    Biological research visual element
    Therapeutics insights

    ICON's therapeutic experts contribute regularly to industry publications and the creation of thought leadership content. Read more.

  • Insights
    Insights
    Digital Disruption Patient Centricity Regulatory Intelligence Therapeutics insights Transforming Trials Value Based Healthcare Blog Videos Webinar Channel
    banners
    From bottlenecks to breakthroughs

    Human-centred strategies for faster study starts

    More than monitoring whitepaper
    More than monitoring

    How modern monitoring paradigms impact CRA roles

    digital globe network with icons
    Meeting requirements for Joint Clinical Assessments

    A planning guide for health technology developers

  • News & Events
    News & Events

    ICON regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards.

    Read more
    Press releases In the News Mediakit Awards Events Webinars Social media
    webinar
    Best practices in global flow cytometry quality control and harmonisation

    5 March 2026. Register today.

    webinar
    When patients lead: Breaking barriers in ultra-rare disease drug development

    3 March 2026. Register today.

  • About ICON
    About ICON
    Company history ICON at a glance ICON in Asia Pacific ICON in Latin America Leadership Quality
    ICON for
    Patients Volunteers Investigators Jobs & Careers Investors Suppliers
    Responsible business practice indicators
    Sustainability, charity, inclusion and belonging

    ICON Cares is our commitment to making a positive impact on our people, environment and our community.

    Modern reception area at Dublin office
    ICON at a glance

    Delivering successful outcomes across the clinical development lifecycle.

  • Careers
  • Investors
  • Contact
  • 日本語
  • 简体中文
  1. Home
  2. Privacy and Data notices
  3. Site Data Protection Notice and Consent

Site Data Protection Notice and Consent

Page tools
Share Share
Facebook

Share on Facebook

Facebook

Share on X

Facebook

Share on Linkedin

Bluesky

Share on Bluesky

ICON Clinical Research Limited and its affiliates (“ICON”) are committed to protecting the privacy of its Clinical Trial Investigators and Study Researchers. To this end, ICON has put in place internal procedures, to ensure that your personal information is processed responsibly and in accordance with applicable laws.

Purposes

The purpose of ICON collecting your personal information is to assess your eligibility for participation in upcoming clinical trials or research studies as an Investigator or Study Researcher. In this context, your personal information is collected when you provide it to us directly, for example when:

  • You express your interest in participating in a trial or study by completing an online survey; or
  • You express your interest in registering with ICON as an Investigator or Study Researcher by contacting ICON via our website located at http://www.iconplc.com/investigators/register/; or
  • You complete a feasibility or prequalification survey for a specific trial or study; or
  • You provide a curriculum vitae or other supporting documents for a study.

We may also collect information about you from publicly available sources such as websites, directories, industry networks etc. This helps us understand your experience and areas of expertise and allows us to keep your information up to date.

If you subsequently participate in a trial or study that is conducted by ICON on behalf of a Sponsor, we will also obtain, process and retain your personal information as part of the management and administration of the trial or study.

Information we collect

The personal information collected by ICON includes your contact information (full name, telephone number, email address) and your professional experience including your area of specialisation and qualifications. ICON also collects information regarding your recruitment and enrolment rates, the types of trials or studies you are interested in and your participation and performance in past and current trials and studies.

When we share your information

As part of the assessment of your eligibility or as part of the conduct of a trial or study, ICON may disclose your personal information to third parties including affiliates, Sponsors, regulatory authorities, vendors, auditors and study related personnel, as required for the evaluation, preparation and conduct of a trial or study.

The recipients of your personal information may be located outside of the European Economic Area which may not have equivalent data protection laws to those applicable in your home country. In such cases, appropriate measures will be taken to protect your personal information in accordance with applicable data protection laws.

For example, we may have your consent to sharing your information, we may put in place EU-approved standard contractual clauses to govern the transfer or we may ensure that the recipient is subject to EU-US or the Swiss-US “Privacy Shield” (in the case of transfers to the United States).

Legal basis for processing

Processing of personal information for the purposes of establishing your eligibility for a trial or study is undertaken on the basis of the consent you provide on this form. ICON and/or the Sponsor may also rely on their legitimate interests to support the processing of your personal data, for example in the course of administering a trial or study or contacting you in relation to your area of specialty. In addition, ICON and the Sponsor will process your information where they are under a legal or regulatory requirement to do so.

Retention

We will retain your personal information on file for the duration of any trial or study in which you participate and for a period thereafter. In the case of clinical trials, this period will be at least 25 years after conclusion of the relevant trial.

Your rights

You have the right to access your personal information, have any errors in your information corrected or to object to the processing of your personal information. In certain circumstances, you may also have the right to have your personal information “ported” to you or to another party or to have your information erased from our systems.

You can exercise these rights by directing a written request to ICON Clinical Research Limited, South County Business Park, Dublin 18, D18 X5R3 (“Controller”) or by sending an email to Data_Privacy_Officer@iconplc.com.

Where we rely on consent to the continued processing of your personal information, you may withdraw your consent at any time by ending a request to the Controller as stated above. You acknowledge that where ICON or the Sponsor have a regulatory obligation or an overriding legitimate interest to retain your personal information, the withdrawal of your consent will not limit the ability of ICON or the Sponsor to continue processing your personal information in line with those legal bases. Please note that if you withdraw consent or
object to us processing your personal information, it may not be possible for you to participate in any research conducted by ICON on behalf of Sponsors.

If you are a data subject covered by the EU General Data Protection Regulation 2016/679 (the “Regulation”) and you are of the opinion that ICON have infringed your rights under this Regulation you have the right to lodge a complaint with the appropriate Data Protection Supervisory Authority in your member State. ICON’s lead Data Protection Supervisory Authority is the Data Protection Commission in Ireland (www.dataprotection.ie)

Consent

By ticking the “I agree” box on the iconplc.com website or in electronic versions of this form or signing a hard copy and returning same to ICON I acknowledge that I have read this Form and, to the extent that my consent is required, I grant my consent to ICON to process, disclose and retain my personal information for the purposes explained above.

Connect with us

  • Contact us
  • Submit proposal request
  • Update Email Preferences
  • Global office locator
  • ICON on social media
Site Branding
    ICON plc
  • Contact
  • About ICON
  • Results & Reports
For Clients
  • Therapeutics
  • Solutions
  • Insights
  • Technologies
  • Content preferences
  • Office locations
ICON for
  • Patients
  • Volunteers
  • Investigators
  • Jobs & Careers
  • Investors
  • Suppliers
News & Events
  • Press releases
  • Mediakit
  • Events
  • Webinars
Socials
  • Linkedin
  • Facebook
  • Instagram
  • Youtube

Legal Footer

  • © 2026 ICON plc
  • Disclaimer
  • Privacy & Data
  • Cookies
How can we help?
  • All
  • Website
Popular search terms:
  • Biotech
  • Cell and Gene Therapies
  • Consulting
  • Early Clinical
  • Medical Device
  • Oncology
  • Rare & Orphan Diseases
  • Real World Evidence
  • Site & Patient Recruitment
  • Strategic Solutions
  • Regulatory Intelligence